Benzinga | Feb 24, 2021 04:09PM EST

OptimizeRx Q4 EPS $0.16 Beats $0.15 Estimate, Sales $16.40M Beat $16.02M Estimate

OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.15 by 6.67 percent. This is a 633.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $16.40 million which beat the analyst consensus estimate of $16.02 million by 2.37 percent. This is a 122.22 percent increase over sales of $7.38 million the same period last year.